Risk factors for Kaposi's sarcoma among HHV-8 seropositive homosexual men with AIDS

International Journal of Cancer

Volumn 115, Issue 2, 2005, Pages 296-300

  Nawar, Eric ^a   Mbulaiteye, Sam M ^a   Gallant, Joel E ^b   Wohl, David A ^c   Ardini, Marianne ^d   Hendershot, Tabitha ^d   Goedert, James J ^a   Rabkin, Charles S ^a,e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d RTI INTERNATIONAL   (United States)

^e MSC 7248 ^*  (United States)

Author keywords

AIDS related malignancy; Human herpesvirus; Kaposi's sarcoma

Indexed keywords

COCAINE; VIRUS GLYCOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICAN AMERICAN; ARTICLE; BISEXUALITY; CIGARETTE SMOKING; COLLEGE; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPEAN AMERICAN; HOMOSEXUALITY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INCOME; INFECTION RISK; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTITUTION; RISK FACTOR; SEROPREVALENCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HERPESVIRUS 8, HUMAN; HIV SEROPOSITIVITY; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; ODDS RATIO; RISK FACTORS; SARCOMA, KAPOSI; VIRAL LOAD; VIRAL PROTEINS;

EID: 17844373305     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20887     Document Type: Article

References (27)

1. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiolpgy of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996;2:918-24.
2. Mbulaiteye SM, Parkin DM, Rabkin CS. Epidemiology of AIDS-related malignancies: an international perspective. Hematol Oncol Clin North Am 2003;17:673-96.
3. Moore P, Chang Y. Kaposi's sarcoma (KS), KS-associated herpes-virus, and the criteria for causality in the age of molecular biology. Am J Epidemiol 1998;147:217-21.
4. Mbulaiteye SM, Biggar RJ, Bakaki PM, Pfeiffer RM, Whitby D, Owor AM, Katongole-Mbidde E, Goedert JJ, Ndugwa CM, Engels EA. Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda. J Natl Cancer Inst 2003;95:1330-5.
5. Bernstein KT, Jacobson LP, Jenkins FJ, Vlahov D, Armenian HK. Factors associated with human herpesvirus type 8 infection in an injecting drug user cohort. Sex Transm Dis 2003;30:199-204.
6. Challine D, Roudot-Thoraval F, Sarah T, Laperche L, Boisson B, Mauberquez S, Dubernet F, Rigot P, Lefrere F, Mercier B, Brossard Y, Rouet F, et al. Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses. Transfusion 2001;41:1120-5.
7. Renwick N, Dukers HTM, Jan Weverling G, Sheldon JA, Schulz TF, Prins M, Coutinho RA, Goudsmit J. Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands. J Infect Dis 2002;185:1808-12.
8. Grulich AE, Kaldor JM, Hendry O, Luo K, Bodsworth NJ, Cooper DA. Risk of Kaposi's sarcoma and oroanal sexual contact. Am J Epidemiol 1997;8:673-9.
9. Melbye M, Cook PM, Hjalgrim H, Begtrup K, Simpson GR, Biggar RJ, Ebbesen P, Schulz TF. Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer 1998;77:543-8.
10. O'Brien TR, Kedes D, Ganem D, Macrae DR, Rosenberg PS, Molden J, Goedert JJ. Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma. J Infect Dis 1999;180:1010-7.
11. Renwick N, Halaby T, Weverling GJ, Dukers NH, Simpson GR, Coutinho RA, Lange JM, Schulz TF, Goudsmit J. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 1998;12:2481-8.
12. Jacobson LP, Jenkins FJ, Springer G, Munoz A, Shah KV, Phair J, Zhang Z, Armenian H. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J Infect Dis 2000;181:1940-9.
13. Centers for Disease Control and Prevention, 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41: 1-19.
14. Engels EA, Whitby D, Goebel PB, Stossel A, Waters D, Pintus A, Contu L, Biggar RJ, Goedert JJ. Identifying human herpesvirus 8 infection: performance characteristics of serologic assays. J Acquir Immune Defic Syndr 2000;23:346-54.
15. Mbulaiteye SM, Pfeiffer RM, Whitby D, Brubaker GR, Shao J, Biggar RJ. Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis 2003;187:1780-5.
16. Breslow NE, Day NE. Statistical methods in cancer research, vol. 2. The design and analysis of cohort studies. Lyon: IARC, 1987.
17. Zhang J, Yu KF. What's the relative risk? a method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998;280:1690-1.
18. Engels EA, Biggar RJ, Marshall VA, Walters MA, Gamache CJ, Whitby D, Goedert JJ. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS 2003;17:1847-51.
19. Cannon MJ, Dollard SC, Black JB, Edlin BR, Hannah C, Hogan SE, Patel MM, Jaffe HW, Offermann MK, Spira TJ, Pellett PE, Gunthel CJ. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus. AIDS 2003;17:215-22.
20. Quinlivan EB, Zhang C, Stewart PW, Komoltri C, Davis MG, Wehbie RS. Elevated virus load of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. J Infect Dis 2002;185:1736-44.
21. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998;338:948-54.
22. Goedert JJ, Vitale F, Lauria C, Serraino D, Tamburini M, Montella M, Messina A, Brown EE, Rezza G, Gafa L, Romano N, Classical Kaposi's Sarcoma Working Group. Risk factors for classical Kaposi's sarcoma. J Natl Cancer Inst 2002;94:1712-8.
23. Hoover DR, Black C, Jacobson LP, Martinez-Maza O, Seminara D, Saah A, Von Roenn J, Anderson R, Armenian HK. Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 1993;138:266-78.
24. Gates AE, Kaplan LD. AIDS malignancies in the era of highly active antiretroviral therapy. Oncology 2002; 16:441-51, 56,59,657-65.
25. Blanchard JC, Haywood YC, Scott C. Racial and ethnic disparities in health: an emergency medicine perspective. Acad Emerg Med 2003;10:1289-93.
26. Halder RM, Bang KM. Skin cancer in blacks in the United States. Dermatol Clin 1988;6:397-405.
27. Rabkin CS, Schulz TF, Whitby D, Lennette ET, Magpantay LI, Chatlynne L, Biggar RJ. Interassay correlation of human herpesvirus 8 serologic tests: HHV-8 Interlaboratory Collaborative Group. J Infect Dis 1998;178:304-9.